Anthrax: Laboratory Testing
On this page:
- Specimen Collection & Shipping
- Lab Procedures & Protocols
- Historical Archives: 2001 Outbreak & Other Incidents
- Additional Research & References
-
Specimen Collection & Shipping
- Acceptable Biological Specimens Needed for Testing for Anthrax
Feb 2006 - Inhalation Anthrax: Recommended Specimens for Microbiology & Pathology for Diagnosis
Feb 2006 - Cutaneous Anthrax: Recommended Specimens for Microbiology & Pathology for Diagnosis
Feb 2006 - Collecting, Preparing, & Shipping Serum Samples to CDC for Serology Testing
Feb 2006 - Comprehensive Procedures for Collecting Environmental Samples for Culturing Bacillus anthracis
Apr 26, 2002 -
Lab Procedures & Protocols
- Q & A: Laboratory Testing
For the public. Effectiveness, home test kits, getting screened, Mayo Clinic/Roche Rapid Anthrax test...
Jun 2, 2003 -
Q & A: Laboratory Safety
Keeping lab workers safe...
Jun 2, 2003 - Algorithm for Laboratory Diagnosis of Anthrax
Feb 2006 - Basic Diagnostic Testing Protocols for Level A Laboratories for the Presumptive Identification of Bacillus anthracis
(413 KB/18 pages)
NOTE: Protocols for sentinel laboratories are no longer posted on the CDC website. The American Society for Microbiology has agreed to take the lead in the development & dissemination of sentinel laboratory information. Information for reference laboratories will continue to be available on the Laboratory Response Network secure website (for questions, e-mail lrn@cdc.gov; tollfree HelpDesk 1-866-LRN-LABS [1-866-576-5227]). The CDC subject matter experts on individual organisms remain available for discussion as always.
Mar 18, 2002 - Approved Tests for the Detection of Bacillus anthracis in the U.S. Laboratory Response Network
Jan 28, 2001 Historical Archives: 2001 Outbreak & Other Incidents
-
Laboratory Response to Anthrax Bioterrorism, New York City, 2001
Emerging Infectious Diseases 2002 Oct;8(10):1096-1102. -
Importance of Bacillus anthracis Molecular Subtyping During the Recent Multi-State Bioterrorism-Associated Anthrax Outbreak in the United States
Archived video webcast from the International Conference on Emerging Infectious Diseases (ICEID)
Alex Hoffmaster, CDC, Atlanta, GA
Mar 26, 2002 -
Rapid Adaptation of a Serologic Assay for the Bioterrorism-Related Anthrax Outbreak—October–December, 2001
Archived video webcast from the International Conference on Emerging Infectious Diseases (ICEID)
Carolyn Greene, CDC, Atlanta, GA
Mar 26, 2002 -
Additional Research & References
- Ruling Out Bacillus anthracis
Emerging Infectious Diseases 2004 Apr;10(4): 732-735 - Nonhemolytic, Nonmotile Gram-Positive Rods Indicative of Bacillus anthracis
Emerging Infectious Diseases 2003 Aug;9(8):1013-1015. - Molecular Subtyping of Bacillus anthracis & the 2001 Bioterrorism-Associated Anthrax Outbreak, United States
Emerging Infectious Diseases 2002 Oct;8(10):1111-1116. - Specific, Sensitive, & Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen
Emerging Infectious Diseases 2002 Oct;8(10):1103-1110. - A Two-Component Direct Fluorescent-Antibody Assay for Rapid Identification of Bacillus anthracis
Emerging Infectious Diseases 2002 Oct;8(10):1060-1065. - Sequencing of 16S rRNA Gene: A Rapid Tool for Identification of Bacillus anthracis
Emerging Infectious Diseases 2002 Oct;8(10):1117-1123. - Recognition of Illness Associated with the Intentional Release of a Biologic Agent
MMWR 2001 Oct 19;50(41):893-897.
PDF (168 KB/20 pages)